Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

820
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
820
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

923
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
923
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Seizures: Classification01:13

Seizures: Classification

1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disinformation and misinformation in epilepsy: An analysis of multiplatform short-form social media video content.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Predicting post-surgical visuospatial memory performance in people with drug-resistant epilepsy.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

A deep representation learning model to predict response to vagus nerve stimulation.

Nature communications·2026
Same author

Optimal approach to standardized documentation in epilepsy clinics: A scoping review.

Epilepsia·2026
Same author

Screening and Management of Depression and Anxiety in People With Epilepsy: A Quality Improvement Study.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025
Same author

Cenobamate for Drug-Resistant Epilepsy: Initial Experience from a Single Tertiary Center.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025

Related Experiment Video

Updated: Jan 10, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.8K

TÉCUM: A New Transition Program for Young People With Epilepsy.

Ya Ning Zhao1, Laury-Anne Blondeau1,2, Rose-Marie Drouin-Engler1,2

  • 1Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Canada.

Neurology. Clinical Practice
|November 24, 2025
PubMed
Summary

The TÉCUM program supports adolescents with epilepsy transitioning to adult care. It offers educational symposia, resources, and psychosocial assessments to improve epilepsy management and well-being.

More Related Videos

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.3K
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.4K

Related Experiment Videos

Last Updated: Jan 10, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

1.8K
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.3K
TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
10:58

TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

Published on: December 28, 2010

17.4K

Area of Science:

  • Neurology
  • Adolescent Medicine
  • Health Services Research

Background:

  • Transitioning pediatric to adult healthcare for epilepsy patients is crucial.
  • Adolescents with epilepsy encounter significant health and social challenges.
  • These challenges include psychiatric issues, adherence problems, and family planning concerns.

Purpose of the Study:

  • To establish a sustainable model for epilepsy transition care.
  • To address the complex medical and psychosocial needs of adolescents with epilepsy.
  • To improve patient well-being during the transition to adult healthcare.

Main Methods:

  • The TÉCUM (Transition en Épilepsie Complexe de l'Université de Montréal) program was developed.
  • Initiatives include patient symposia, a resource website, and a psychosocial assessment questionnaire.
  • The program aims to tailor interventions based on individual patient needs.

Main Results:

  • The program has implemented novel educational initiatives for patients and families.
  • Measures are in place to optimize epilepsy management and psychosocial support.
  • The TÉCUM program provides a structured approach to transition care.

Conclusions:

  • The TÉCUM program offers an innovative model for epilepsy transition care.
  • It addresses both medical and psychosocial aspects critical for adolescents.
  • The program is expected to benefit young people with epilepsy nationwide.